303 related articles for article (PubMed ID: 36051940)
1. Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk.
Cidade JP; Coelho LM; Costa V; Morais R; Moniz P; Morais L; Fidalgo P; Tralhão A; Paulino C; Nora D; Valério B; Mendes V; Tapadinhas C; Povoa P
World J Crit Care Med; 2022 Jul; 11(4):246-254. PubMed ID: 36051940
[TBL] [Abstract][Full Text] [Related]
2. Classification of Septic Shock Phenotypes Based on the Presence of Hypotension and Hyperlactatemia in Cats.
Troia R; Buzzurra F; Ciuffoli E; Mascalzoni G; Foglia A; Magagnoli I; Dondi F; Giunti M
Front Vet Sci; 2021; 8():692528. PubMed ID: 34595228
[No Abstract] [Full Text] [Related]
3. Evaluation of a novel 5-group classification system of sepsis by vasopressor use and initial serum lactate in the emergency department.
Swenson KE; Dziura JD; Aydin A; Reynolds J; Wira CR
Intern Emerg Med; 2018 Mar; 13(2):257-268. PubMed ID: 28132131
[TBL] [Abstract][Full Text] [Related]
4. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock.
Ranzani OT; Monteiro MB; Ferreira EM; Santos SR; Machado FR; Noritomi DT;
Rev Bras Ter Intensiva; 2013; 25(4):270-8. PubMed ID: 24553507
[TBL] [Abstract][Full Text] [Related]
5. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock.
Thomas-Rueddel DO; Poidinger B; Weiss M; Bach F; Dey K; Häberle H; Kaisers U; Rüddel H; Schädler D; Scheer C; Schreiber T; Schürholz T; Simon P; Sommerer A; Schwarzkopf D; Weyland A; Wöbker G; Reinhart K; Bloos F;
J Crit Care; 2015 Apr; 30(2):439.e1-6. PubMed ID: 25466313
[TBL] [Abstract][Full Text] [Related]
6. Do Sepsis-3 Criteria Facilitate Earlier Recognition of Sepsis and Septic Shock? A Retrospective Cohort Study.
Scheer CS; Kuhn SO; Fuchs C; Vollmer M; Modler A; Brunkhorst F; Shankar-Hari M; Hahnenkamp K; Gründling M; Rehberg S
Shock; 2019 Mar; 51(3):306-311. PubMed ID: 30422118
[TBL] [Abstract][Full Text] [Related]
7. [Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].
Zhao M; Duan M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):449-453. PubMed ID: 32527351
[TBL] [Abstract][Full Text] [Related]
8. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
9. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
10. [Intestinal barrier dysfunction and its related factors in patients with sepsis].
Liu W; Wang XH; Yang XJ; Zhang XY; Qi WJ
Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(44):3568-3572. PubMed ID: 27916077
[No Abstract] [Full Text] [Related]
11. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis-3).
Yang WS; Kang HD; Jung SK; Lee YJ; Oh SH; Kim YJ; Sohn CH; Kim WY
Clin Respir J; 2020 Sep; 14(9):857-863. PubMed ID: 32438528
[TBL] [Abstract][Full Text] [Related]
12. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
[TBL] [Abstract][Full Text] [Related]
13. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb
Paul R; Sathe P; Kumar S; Prasad S; Aleem M; Sakhalvalkar P
World J Crit Care Med; 2021 Jan; 10(1):22-34. PubMed ID: 33505870
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock.
Sterling SA; Puskarich MA; Shapiro NI; Trzeciak S; Kline JA; Summers RL; Jones AE;
Shock; 2013 Jul; 40(1):11-4. PubMed ID: 23649098
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria.
Manjappachar NK; Cuenca JA; Ramírez CM; Hernandez M; Martin P; Reyes MP; Heatter AJ; Gutierrez C; Rathi N; Sprung CL; Price KJ; Nates JL
J Natl Compr Canc Netw; 2022 Jan; 20(1):45-53. PubMed ID: 34991066
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of etomidate in severe sepsis and septic shock.
Dmello D; Taylor S; O'Brien J; Matuschak GM
Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of early septic shock-related thrombocytopenia and its impact on prognosis].
Xu X; Wang H; Wu X; Yu J; Zheng R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):938-943. PubMed ID: 34590560
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial.
Demiselle J; Wepler M; Hartmann C; Radermacher P; Schortgen F; Meziani F; Singer M; Seegers V; Asfar P;
Ann Intensive Care; 2018 Sep; 8(1):90. PubMed ID: 30225670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
